NCT05193188 2023-02-16A Study of Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade ChondrosarcomaSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 2 Unknown70 enrolled